Overview

Persistence Targeted Smoking Cessation in Schizophrenia

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The investigators will conduct a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention.
Phase:
Phase 4
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Nicotine